C. D. Bloomfield
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Molecular Biology top 0.5%
- Gene expression and cancer classification
- Bioinformatics and Genomic Networks
- Molecular Biology Techniques and Applications
- Machine Learning in Bioinformatics
Papers in
- Hematology 32
- Acute Myeloid Leukemia Research 27
- Chronic Myeloid Leukemia Treatments 9
-
- Acute Lymphoblastic Leukemia research 24
- Co-authors
- M. A. Caligiuri (5 shared papers)Pablo Tamayo (1 shared paper)Jill P. Mesirov (1 shared paper)Todd R. Golub (1 shared paper)C. Huard (1 shared paper)James R. Downing (1 shared paper)Hilary A. Coller (1 shared paper)Mignon L. Loh (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)Haematologica (3 papers)Cancer (2 papers)British Journal of Haematology (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
C. D. Bloomfield
51 papers receiving 11.2k citations
C. D. Bloomfield's Hit Papers
Peers
Comparison fields: 5 of 170
- Hematology 2.5k
- Molecular Biology 7.5k
- Genetics 1.0k
- Cancer Research 1.0k
- Pathology and Forensic Medicine 1.2k
Countries citing papers authored by C. D. Bloomfield
This map shows the geographic impact of C. D. Bloomfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. D. Bloomfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. D. Bloomfield more than expected).
Fields of papers citing papers by C. D. Bloomfield
This network shows the impact of papers produced by C. D. Bloomfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. D. Bloomfield. The network helps show where C. D. Bloomfield may publish in the future.
Co-authors
The 25 scholars most cited alongside C. D. Bloomfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring Hit paper breakdown → | 1999 | 8040 |
| 2 | The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues Hit paper breakdown → | 1999 | 649 |
| 3 | Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. Hit paper breakdown → | 1990 | 617 |
| 4 | 1985 | 255 | |
| 5 | 2000 | 240 | |
| 6 | Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. | 1992 | 233 |
| 7 | Clinical significance of cytogenetics in acute myeloid leukemia. | 1997 | 202 |
| 8 | 1997 | 180 | |
| 9 | Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. | 1998 | 169 |
| 10 | 1989 | 147 | |
| 11 | Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. | 1996 | 143 |
| 12 | 1997 | 102 | |
| 13 | 2013 | 68 | |
| 14 | Effect of age on therapeutic response and survival in advanced Hodgkin's disease. | 1982 | 67 |
| 15 | Chromosomal abnormalities in acute lymphoblastic leukemia. | 1981 | 65 |
| 16 | B-cell markers on lymphoblasts in acute lymphoblastic leukaemia. | 1974 | 45 |
| 17 | Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies. | 1982 | 43 |
| 18 | 1992 | 39 | |
| 19 | 1989 | 39 | |
| 20 | 2000 | 38 |
About C. D. Bloomfield
C. D. Bloomfield is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine, Molecular Biology and Genetics, having authored 52 papers that have together received 11.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (24 papers), Lymphoma Diagnosis and Treatment (12 papers), Chronic Myeloid Leukemia Treatments (9 papers), Retinoids in leukemia and cellular processes (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Cancer Treatment and Pharmacology (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (2.5k citations), Molecular Biology (7.5k citations), Genetics (1.0k citations), Cancer Research (1.0k citations) and Pathology and Forensic Medicine (1.2k citations). C. D. Bloomfield has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include M. A. Caligiuri, Pablo Tamayo, Jill P. Mesirov, Todd R. Golub, C. Huard, James R. Downing, Hilary A. Coller, Mignon L. Loh, Eric S. Lander and Michelle Gaasenbeek. Their work appears in journals such as Journal of Clinical Oncology, Haematologica, Cancer, British Journal of Haematology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.